Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Roger Douglas Weiss, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21DA041682 (CHAN, KEVIN E) Mar 15, 2017 - Feb 28, 2019
    NIH
    Opioid Use and Abuse in the Dialysis Population
    Role: Co-Principal Investigator
  2. K24DA022288 (WEISS, ROGER D.) Apr 1, 2007 - Mar 1, 2019
    NIH
    Mentoring in drug abuse and dual diagnosis research
    Role: Principal Investigator
  3. UG1DA015831 (D'ONOFRIO, GAIL) Sep 30, 2002 - Feb 28, 2025
    NIH
    The National Drug Abuse Clinical Trials Network: New England Consortium Node
    Role: Co-Principal Investigator
  4. U10DA015831 (WEISS, ROGER D.) Sep 30, 2002 - Aug 31, 2015
    NIH
    The National Drug Abuse Treatment Clinical Trials Network (U10)
    Role: Co-Principal Investigator
  5. R01DA015968 (WEISS, ROGER D.) Sep 30, 2002 - Jan 31, 2009
    NIH
    Modifying Group Therapy for Bipolar Abusers
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sugarman DE, Busch AB, McHugh RK, Bogunovic OJ, Trinh CD, Weiss RD, Greenfield SF. Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic. Am J Addict. 2021 09; 30(5):445-452. PMID: 34405475.
    Citations:    Fields:    
  2. Strain EC, Kampman KM, Weiss RD. Moving Beyond Medications That Act at the µ Receptor in the Treatment of Opioid Use Disorder. JAMA Psychiatry. 2021 Jul 01; 78(7):701-702. PMID: 33851964.
    Citations:    Fields:    
  3. Hilton BT, Yusufov M, Rosellini AJ, Taghian NR, Weiss RD, Griffin ML, McHugh RK. Psychometric properties of the Anxiety Sensitivity Index-3 in adults with substance use disorders. J Subst Abuse Treat. 2021 Jun 03; 132:108507. PMID: 34214925.
    Citations:    Fields:    
  4. Suzuki J, Weiss RD. Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence? J Addict Med. 2021 04 01; 15(2):91-92. PMID: 32909980.
    Citations:    Fields:    Translation:HumansAnimals
  5. Shulman M, Weiss R, Rotrosen J, Novo P, Costello E, Nunes EV. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)". Addict Sci Clin Pract. 2021 03 06; 16(1):15. PMID: 33676577.
    Citations:    Fields:    
  6. Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply. J Addict Med. 2020 12; 14(6):518-519. PMID: 32187110.
    Citations:    Fields:    Translation:Humans
  7. Kneeland ET, Peckham AD, McHugh RK, Weiss RD, Beard C, Björgvinsson T. Tobacco Use Predicts Treatment Dropout and Outcome in an Acute, Transdiagnostic Psychiatric Treatment Setting. Behav Ther. 2021 07; 52(4):897-906. PMID: 34134829.
    Citations:    Fields:    Translation:Humans
  8. Becker WC, Krebs EE, Edmond SN, Lin LA, Sullivan MD, Weiss RD, Gordon AJ. A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference. J Gen Intern Med. 2020 12; 35(Suppl 3):978-982. PMID: 33145681.
    Citations:    Fields:    Translation:Humans
  9. Taghian NR, McHugh RK, Griffin ML, Chase AR, Greenfield SF, Weiss RD. Associations between Childhood Abuse and Chronic Pain in Adults with Substance Use Disorders. Subst Use Misuse. 2021; 56(1):87-92. PMID: 33131372.
    Citations:    Fields:    Translation:Humans
  10. McHugh RK, Trinh CD, Griffin ML, Weiss RD. Validation of the craving scale in a large sample of adults with substance use disorders. Addict Behav. 2021 02; 113:106651. PMID: 33086155.
    Citations:    Fields:    Translation:Humans
  11. Lipsitz SR, Fitzmaurice GM, Weiss RD. Using Multiple Imputation with GEE with Non-monotone Missing Longitudinal Binary Outcomes. Psychometrika. 2020 12; 85(4):890-904. PMID: 33006740.
    Citations:    Fields:    
  12. Kimmel SD, Walley AY, Li Y, Linas BP, Lodi S, Bernson D, Weiss RD, Samet JH, Larochelle MR. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis. JAMA Netw Open. 2020 10 01; 3(10):e2016228. PMID: 33052402.
    Citations: 4     Fields:    Translation:Humans
  13. Weiss RD. Establishing the First Annual Meetings of the American Academy of Addiction Psychiatry. Am J Addict. 2020 09; 29(5):373-374. PMID: 32902043.
    Citations:    Fields:    Translation:Humans
  14. McHugh RK, Geyer RB, Chase AR, Griffin ML, Bogunovic O, Weiss RD. Sex differences in benzodiazepine misuse among adults with substance use disorders. Addict Behav. 2021 01; 112:106608. PMID: 32861991.
    Citations: 1     Fields:    Translation:Humans
  15. Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. J Addict Med. 2020 Jul/Aug; 14(4):282-286. PMID: 31634202.
    Citations: 3     Fields:    Translation:Humans
  16. McHugh RK, Votaw VR, Taghian NR, Griffin ML, Weiss RD. Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use. J Subst Abuse Treat. 2020 10; 117:108061. PMID: 32811622.
    Citations: 1     Fields:    Translation:Humans
  17. King CD, Hilton BT, Greenfield SF, McHugh RK, Griffin ML, Weiss RD, Ressler KJ. Anxiety sensitivity and grit as mediators between childhood abuse and relapse risk for substance use. Child Abuse Negl. 2020 09; 107:104568. PMID: 32559552.
    Citations:    Fields:    Translation:Humans
  18. Votaw VR, Witkiewitz K, Vowles KE, Weiss RD, Griffin ML, McHugh RK. Pain interference and catastrophizing are not associated with polysubstance use among treatment-seeking patients with substance use disorders and chronic pain. Am J Drug Alcohol Abuse. 2020 09 02; 46(5):604-612. PMID: 32529847.
    Citations: 1     Fields:    Translation:Humans
  19. Peckham AD, Griffin ML, McHugh RK, Weiss RD. Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder. Drug Alcohol Depend. 2020 Jun 12; 213:108122. PMID: 32563846.
    Citations: 2     Fields:    
  20. Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, McRae-Clark AL, Montoya I, Peters EN, Ramey T, Turk DC, Vandrey R, Weiss RD, Strain EC. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug Alcohol Depend. 2020 07 01; 212:107993. PMID: 32360455.
    Citations: 5     Fields:    Translation:Humans
  21. McHugh RK, Janes AC, Griffin ML, Taghian N, Greenfield SF, Weiss RD. Clinical Correlates of Smoking Status in Men and Women with Opioid Use Disorder. Subst Use Misuse. 2020; 55(7):1054-1058. PMID: 32037945.
    Citations: 1     Fields:    Translation:Humans
  22. Connery HS, Weiss RD. Discontinuing Buprenorphine Treatment of Opioid Use Disorder: What Do We (Not) Know? Am J Psychiatry. 2020 02 01; 177(2):104-106. PMID: 32008394.
    Citations: 2     Fields:    Translation:Humans
  23. Fitzmaurice GM, Lipsitz SR, Weiss RD. Within-treatment frequency of use versus abstinence as a predictor of longitudinal post-treatment follow-up assessments of drug use. Drug Alcohol Depend. 2020 03 01; 208:107857. PMID: 31968301.
    Citations:    Fields:    Translation:Humans
  24. Suzuki J, Robinson D, Mosquera M, Solomon DA, Montgomery MW, Price CD, Johnson JA, Martin B, Liebschutz JW, Schnipper JL, Weiss RD. Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis. Am J Addict. 2020 03; 29(2):155-159. PMID: 31930608.
    Citations: 2     Fields:    Translation:Humans
  25. Pedrelli P, Borsari B, Merrill JE, Fisher LB, Nyer M, Shapero BG, Farabaugh A, Hayden ER, Levine MT, Fava M, Weiss RD. Evaluating the combination of a Brief Motivational Intervention plus Cognitive Behavioral Therapy for Depression and heavy episodic drinking in college students. Psychol Addict Behav. 2020 Mar; 34(2):308-319. PMID: 31855009.
    Citations: 1     Fields:    Translation:Humans
  26. Copersino ML, Patel R, Price JS, Visser KF, Vitaliano G, Plitman E, Lukas SE, Weiss RD, Janes AC, Chakravarty MM. Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry. Drug Alcohol Depend. 2020 01 01; 206:107728. PMID: 31740207.
    Citations:    Fields:    Translation:Humans
  27. Kleykamp BA, Weiss RD, Strain EC. Time to Reconsider the Role of Craving in Opioid Use Disorder. JAMA Psychiatry. 2019 11 01; 76(11):1113-1114. PMID: 31339512.
    Citations: 1     Fields:    Translation:Humans
  28. McDermott KA, Griffin ML, McHugh RK, Fitzmaurice GM, Jamison RN, Provost SE, Weiss RD. Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder. Drug Alcohol Depend. 2019 12 01; 205:107675. PMID: 31715440.
    Citations: 2     Fields:    Translation:Humans
  29. Beard C, Peckham AD, Griffin ML, Weiss RD, Taghian N, McHugh RK. Associations among interpretation bias, craving, and abstinence self-efficacy in adults with substance use disorders. Drug Alcohol Depend. 2019 12 01; 205:107644. PMID: 31698320.
    Citations:    Fields:    Translation:Humans
  30. Kleykamp BA, De Santis M, Dworkin RH, Huhn AS, Kampman KM, Montoya ID, Preston KL, Ramey T, Smith SM, Turk DC, Walsh R, Weiss RD, Strain EC. Craving and opioid use disorder: A scoping review. Drug Alcohol Depend. 2019 12 01; 205:107639. PMID: 31683241.
    Citations: 3     Fields:    Translation:Humans
  31. Connery HS, Taghian N, Kim J, Griffin M, Rockett IRH, Weiss RD, Kathryn McHugh R. Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder. Drug Alcohol Depend. 2019 12 01; 205:107612. PMID: 31627077.
    Citations: 5     Fields:    Translation:Humans
  32. McHugh RK, Kneeland ET, Edwards RR, Jamison R, Weiss RD. Pain catastrophizing and distress intolerance: prediction of pain and emotional stress reactivity. J Behav Med. 2020 08; 43(4):623-629. PMID: 31376099.
    Citations: 1     Fields:    Translation:Humans
  33. Kelly JF, Hoffman L, Vilsaint C, Weiss R, Nierenberg A, Hoeppner B. Peer support for mood disorder: Characteristics and benefits from attending the Depression and Bipolar Support Alliance mutual-help organization. J Affect Disord. 2019 08 01; 255:127-135. PMID: 31150942.
    Citations: 1     Fields:    Translation:Humans
  34. Kneeland ET, Griffin ML, Taghian N, Weiss RD, McHugh RK. Associations between pain catastrophizing and clinical characteristics in adults with substance use disorders and co-occurring chronic pain. Am J Drug Alcohol Abuse. 2019; 45(5):488-494. PMID: 31021654.
    Citations: 4     Fields:    Translation:Humans
  35. Carroll KM, Weiss RD. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. Focus (Am Psychiatr Publ). 2019 Apr; 17(2):183-192. PMID: 32021588.
    Citations:    
  36. Weiss RD, Griffin ML, Marcovitz DE, Hilton BT, Fitzmaurice GM, McHugh RK, Carroll KM. Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence. J Clin Psychiatry. 2019 03 26; 80(2). PMID: 30920187.
    Citations: 5     Fields:    Translation:Humans
  37. Beckwith N, McDowell MJ, Reisner SL, Zaslow S, Weiss RD, Mayer KH, Keuroghlian AS. Psychiatric Epidemiology of Transgender and Nonbinary Adult Patients at an Urban Health Center. LGBT Health. 2019 Feb/Mar; 6(2):51-61. PMID: 30707624.
    Citations: 8     Fields:    Translation:Humans
  38. McHugh RK, Weiss RD. Alcohol Use Disorder and Depressive Disorders. Alcohol Res. 2019 10 21; 40(1). PMID: 31649834.
    Citations: 13     Fields:    Translation:Humans
  39. Kiluk BD, Fitzmaurice GM, Strain EC, Weiss RD. Response to commentaries: The quest(ion) remains in the search for a meaningful reduction-based end-point. Addiction. 2019 01; 114(1):21-23. PMID: 30474162.
    Citations:    Fields:    Translation:Humans
  40. Connery HS, Weiss RD. Microscopes and Telescopes: the Societal Impact of Substance Use Disorder Treatment. Am J Psychiatry. 2018 10 01; 175(10):925-926. PMID: 30269546.
    Citations:    Fields:    Translation:Humans
  41. Fitzmaurice GM, Lipsitz SR, Weiss RD. Sensitivity analysis for non-monotone missing binary data in longitudinal studies: Application to the NIDA collaborative cocaine treatment study. Stat Methods Med Res. 2019 Oct-Nov; 28(10-11):3057-3073. PMID: 30146938.
    Citations:    Fields:    Translation:Humans
  42. McHugh RK, Geyer R, Karakula S, Griffin ML, Weiss RD. Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use. Am J Addict. 2018 09; 27(6):485-490. PMID: 30028048.
    Citations: 7     Fields:    Translation:Humans
  43. Faberman J, Provost SE, Weiss RD, Greenfield SF. Focus Group Study to Examine Content of Family Meetings in Short-term Substance Use Disorder Treatment. J Soc Work Pract Addict. 2018; 18(3):231-248. PMID: 30505244.
    Citations:   &